Roche (RHHBY) News Today $40.49 -0.73 (-1.77%) As of 07/11/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartDividendHeadlinesInsider TradesOwnershipShort InterestBuy This Stock RHHBY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Roche Holding AG (OTCMKTS:RHHBY) Receives Average Recommendation of "Moderate Buy" from AnalystsJuly 12 at 2:39 AM | americanbankingnews.comRoche Holding AG (OTCMKTS:RHHBY) Receives Average Recommendation of "Moderate Buy" from BrokeragesJuly 12 at 2:37 AM | marketbeat.comPharma Companies Remain Calm Amid Fresh Tariff Threat by TrumpJuly 11 at 11:11 AM | theglobeandmail.comRoche Holding AG (OTCMKTS:RHHBY) Shares Bought by Moloney Securities Asset Management LLCJuly 9, 2025 | marketbeat.comRHHBY - Roche Holding AG ADR Sustainability - MorningstarJuly 8, 2025 | morningstar.comMRHHBY - Roche Holding AG ADR Chart - MorningstarJuly 3, 2025 | morningstar.comMChanges to the Roche Enlarged Corporate Executive CommitteeJune 30, 2025 | globenewswire.comRHHBY - Roche Holding AG ADR Trailing Returns - MorningstarJune 27, 2025 | morningstar.comMRHHBY Roche Holding AG - Seeking AlphaJune 27, 2025 | seekingalpha.comRHHBY - Roche Holding AG ADR Key Metrics - MorningstarJune 25, 2025 | morningstar.comMRHHBY - Roche Holding AG ADR Dividends - MorningstarJune 24, 2025 | morningstar.comMRoche Holding AG (RHHBY) Virtual Hematology Investor Conference TranscriptJune 23, 2025 | seekingalpha.comEarly data suggest Roche’s NXT007 may have the potential to provide haemostatic normalisation in people with haemophilia AJune 23, 2025 | uk.finance.yahoo.comAltrius Capital Management Inc Acquires 6,545 Shares of Roche Holding AG (OTCMKTS:RHHBY)June 22, 2025 | marketbeat.comRoche’s Lunsumio and Polivy combination significantly prolongs remission for people with relapsed or refractory large B-cell lymphomaJune 20, 2025 | uk.finance.yahoo.comGenentech’s Lunsumio and Polivy Combination Significantly Prolongs Remission for People With Relapsed or Refractory Large B-cell LymphomaJune 20, 2025 | finance.yahoo.comRoche's Genentech reports positive results from lymphoma trialJune 20, 2025 | msn.comGenentech's Lunsumio and Polivy Combination Significantly Prolongs Remission for People With Relapsed or Refractory Large B-cell LymphomaJune 20, 2025 | businesswire.comRoche's Lunsumio and Polivy combination significantly prolongs remission for people with relapsed or refractory large B-cell lymphomaJune 20, 2025 | globenewswire.comUBS Keeps Their Buy Rating on Roche Holding AG (RHHVF)June 18, 2025 | theglobeandmail.comRoche And Prothena: Why Moving On Makes SenseJune 18, 2025 | seekingalpha.comRoche: Despite Venclexta Study Failure, PD Program Is Another Growth AvenueJune 16, 2025 | seekingalpha.comSarepta crashes after second death linked to Roche-partnered ElevidysJune 16, 2025 | msn.comGenentech Provides Update on Phase III Verona StudyJune 16, 2025 | businesswire.comRoche Pauses Commercial and Clinical Use of Elevidys After Fatal Liver FailuresJune 16, 2025 | wsj.comGenentech to Advance Prasinezumab Into Phase III Development for Early-Stage Parkinson’s DiseaseJune 16, 2025 | finance.yahoo.comGenentech to Advance Prasinezumab Into Phase III Development for Early-Stage Parkinson's DiseaseJune 16, 2025 | businesswire.comRoche to advance prasinezumab into Phase III development for early-stage Parkinson's diseaseJune 16, 2025 | globenewswire.com[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys™ gene therapy for Duchenne muscular dystrophy in non-ambulatory patientsJune 15, 2025 | globenewswire.comRhumbline Advisers Has $4.41 Million Holdings in Roche Holding AG (OTCMKTS:RHHBY)June 14, 2025 | marketbeat.comRoche’s Chugai Seeks Next Milestone after Finding Success with Eli Lilly’s Obesity DrugJune 11, 2025 | theglobeandmail.comRoche Holding AG (OTCMKTS:RHHBY) Shares Bought by Bard Financial Services Inc.June 11, 2025 | marketbeat.comAccess Medical Labs, a Subsidiary of Empresas Aries, Completes Historic Lab Expansion with Roche Diagnostics SystemsJune 10, 2025 | globenewswire.com$101.5 Bn Oncology Diagnostics Global Markets, 2023-2024 & 2025-2029 with Profiles of Leading Players - F. Hoffmann-La Roche.June 10, 2025 | globenewswire.comGreen Steel Industry Report 2025-2029 with Profiles of Leading Players - F. Hoffmann-La Roche.June 10, 2025 | globenewswire.comHealth Rounds: Roche's Tecentriq reduces recurrence, deaths for certain colon cancer patientsJune 6, 2025 | reuters.comGAMMA Investing LLC Grows Position in Roche Holding AG (OTCMKTS:RHHBY)June 6, 2025 | marketbeat.comRoche’s Evrysdi tablet approved by European Commission as first and only for Spinal Muscular Atrophy (SMA)June 4, 2025 | finance.yahoo.comRoche's Evrysdi tablet approved by European Commission as first and only for Spinal Muscular Atrophy (SMA)June 4, 2025 | globenewswire.comRoche Holding AG (OTCMKTS:RHHBY) Short Interest Up 35.0% in MayJune 3, 2025 | marketbeat.comRoche's Tecentriq With Lurbinectedin Increases Survival to Small-Cell Lung Cancer, Study SaysJune 3, 2025 | wsj.comRoche's Tecentriq combined with lurbinectedin shows significant survival benefit in extensive-stage small cell lung cancerJune 3, 2025 | globenewswire.comGenentech's Tecentriq Combined with Lurbinectedin Shows Significant Survival Benefit in Extensive-Stage Small Cell Lung CancerJune 2, 2025 | businesswire.comNew Data Show Genentech's Itovebi Significantly Extended Survival in a Certain Type of HR-positive Advanced Breast CancerMay 31, 2025 | businesswire.comNew data show Roche's Itovebi significantly extended survival in a certain type of HR-positive advanced breast cancerMay 31, 2025 | globenewswire.comBoston Common Asset Management LLC Purchases 29,522 Shares of Roche Holding AG (OTCMKTS:RHHBY)May 30, 2025 | marketbeat.comGenentech's Fenebrutinib Maintains Near-Complete Suppression of Disease Activity and Disability Progression for up to Two Years in People With Relapsing Multiple SclerosisMay 30, 2025 | businesswire.comTop Analyst Reports for Alphabet, Bank of America & RocheMay 28, 2025 | msn.comRoche extends trials of antibiotic against resistant superbug, FT reportsMay 28, 2025 | yahoo.comTandem Diabetes, Roche enter patent settlement agreementMay 26, 2025 | finance.yahoo.com Get Roche News Delivered to You Automatically Sign up to receive the latest news and ratings for RHHBY and its competitors with MarketBeat's FREE daily newsletter. Email Address RHHBY Media Mentions By Week RHHBY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RHHBY News Sentiment▼0.510.99▲Average Medical News Sentiment RHHBY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RHHBY Articles This Week▼59▲RHHBY Articles Average Week Get Roche News Delivered to You Automatically Sign up to receive the latest news and ratings for RHHBY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies China Construction Bank News Airbus Group News EssilorLuxottica News Iberdrola News Nintendo News BNP Paribas News Vinci News Atlas Copco News Compass Group News DHL Group News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:RHHBY) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roche Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Roche With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RHHBY Stock Alerts